Research Status, Synthesis and Clinical Application of Antiepileptic Drugs

被引：3
|
作者：
Wang, Si-Jie [1 ]
Zhao, Min-Yan [1 ]
Zhao, Peng-Cheng [1 ]
Zhang, Wen [1 ]
Rao, Guo-Wu [1 ]
机构：
[1] Zhejiang Univ Technol, Inst Drug Dev & Chem Biol, Coll Pharmaceut Sci, Hangzhou 310014, Peoples R China
来源：
CURRENT MEDICINAL CHEMISTRY | 2024年 / 31卷 / 04期
关键词：
Brain dysfunction; epilepsy; antiepileptic drugs (AEDs); drugs targets; GABA; glutamate; CONVULSIVE STATUS EPILEPTICUS; TREATMENT-RESISTANT EPILEPSY; JUVENILE MYOCLONIC EPILEPSY; UNCONTROLLED FOCAL SEIZURES; QUALITY-OF-LIFE; REFRACTORY EPILEPSY; DOUBLE-BLIND; ESLICARBAZEPINE ACETATE; ANTICONVULSANT ACTIVITY; ADJUNCTIVE THERAPY;
D O I：
10.2174/0929867330666230117160632
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
According to the 2017 ILAE's official definition, epilepsy is a slow brain disease state characterized by recurrent episodes. Due to information released by ILAE in 2017, it can be divided into four types, including focal epilepsy, generalized epilepsy, combined generalized, and focal epilepsy, and unknown epilepsy. Since 1989, 24 new antiepileptic drugs have been approved to treat different types of epilepsy. Besides, there are a variety of antiepileptic medications under clinical monitoring. These novel antiepileptic drugs have plenty of advantages. Over the past 33 years, there have been many antiepileptic drugs on the mearket, but no one has been found that can completely cure epilepsy. In this paper, the mentioned drugs were classified according to their targets, and the essential information, and clinical studies of each drug were described. The structure-activity relationship of different chemical structures was summarized. This paper provides help for the follow-up research on epilepsy drugs.
引用
收藏
页码：410 / 452
页数：43
相关论文
共 50 条
  • [31] The next generation of antiepileptic drugs: Oxcarbazepine, levetiracetam, zonisamide - Present status and clinical potential
    Schmidt, D
    NERVENHEILKUNDE, 2000, 19 (10) : 539 - 545
  • [32] Research Status, Synthesis and Clinical Application of Recently Marketed and Clinical BCR-ABL Inhibitors
    Xu, Xiao-Liang
    Cao, Yu-Jing
    Zhang, Wen
    Rao, Guo-Wu
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (17) : 3050 - 3078
  • [33] THE IMPACT OF NEWER ANTIEPILEPTIC DRUGS IN THE TREATMENT OF STATUS EPILEPTICUS
    Rossetti, A. O.
    Jaques, L.
    EPILEPSIA, 2012, 53 : 99 - 99
  • [34] Status epilepticus and encephalopathies in children induced by antiepileptic drugs
    Montero-Contreras, F.
    EPILEPSIA, 2007, 48 : 162 - 162
  • [35] The number of Enteral Antiepileptic Drugs in Refractory Status Epilepticus: Their effect on patient mortality and clinical outcome
    Nughays, Ruaa
    Ibrahim, Bashair
    Shafei, Sohaib
    Ayoub, Omar
    Gaweesh, Ahmed
    Tashkandi, Wail
    Bushnag, Areej
    NEUROLOGY, 2017, 88
  • [36] The use of valproate and new antiepileptic drugs in status epilepticus
    Trinka, Eugen
    EPILEPSIA, 2007, 48 : 49 - 51
  • [37] Antiepileptic drugs and neuroprotection: Current status and future roles
    Willmore, LJ
    EPILEPSY & BEHAVIOR, 2005, 7 : S25 - S28
  • [38] Paradoxical seizures and status epilepticus with newer antiepileptic drugs
    Panda, Samhita
    Joshi, Shambhavi S.
    NEUROLOGY INDIA, 2011, 59 (03) : 479 - U227
  • [39] Current Status of Antiepileptic Drugs as Preventive Migraine Therapy
    Parikh, Simy K.
    Silberstein, Stephen D.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (04)
  • [40] Current Status of the New Antiepileptic Drugs in Chronic Pain
    Sidhu, Harpreet S.
    Sadhotra, Akshay
    FRONTIERS IN PHARMACOLOGY, 2016, 7
12345